Thyroid dysgenesis (TD) is the common pathogenic mechanism of congenital hypothyroidism (CH). In addition, known pathogenic genes are limited to those that are directly involved in thyroid development
Background: Fourteen clinical trials have not shown a consistent benefit of combination therapy with levothyroxine (LT4) and liothyronine (LT3). Despite the publication of these trials,
Supplementary Table 1. Osteoporosis medication codes and diagnostic codes for fractures Supplementary Table 2. Baseline characteristics by presence or absence of hypoparathyroidism in thy
